Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
-469,296
Put/Call ratio
19%
SEC-reported price per share
$5.40
Number of holders
59
Value change
-$5,374,332
Number of buys
35
Open additional details 1 more signal available
Number of sells
24
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
72,227,200

Security key

00509G209

Report period

Q4 2022

Institutions

59

Top holders

10

Ownership snapshot

Top reported holders of ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F Lead comparable stake: 14% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 14%
Deep Track Capital, LP 5.2%
Sands Capital Alternatives, LLC 4.7%
Laurion Capital Management LP 1.7%
GREAT POINT PARTNERS LLC 1.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
14%
$98,001,000
9,770,773 shares
30 Sep 2022
Deep Track Capital, LP
13F
Company
13F
5.2%
$37,902,000
3,778,818 shares
30 Sep 2022
Sands Capital Alternatives, LLC
13F
Company
13F
4.7%
$34,273,000
3,417,075 shares
30 Sep 2022
Laurion Capital Management LP
13F
Company
13F
1.7%
$12,101,000
1,206,548 shares
30 Sep 2022
GREAT POINT PARTNERS LLC
13F
Company
13F
1.7%
$12,036,000
1,200,000 shares
30 Sep 2022
BlackRock Finance, Inc.
13F
Company
13F
1.5%
$11,184,000
1,115,027 shares
30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
59
Shares
28,727,743
Rows available
59
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
48
Q4 2022 holders
59
Holder diff
11
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .